Project Grant R01AG096160
- This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to study the impact of hospice care on the well-being of Alzheimer's disease (AD) patients and their family members. The $318,416 project will leverage natural experiments from the opening of new hospice facilities to estimate the effects of hospice utilization on patient outcomes such as pain management, depression, and activities of daily living. It will...
- The National Institute on Aging, a component of the Department of Health and Human Services National Institutes of Health, awarded $819,959 to The Regents of the University of California, San Francisco on September 3, 2026, under the Aging Research program (CFDA 93.866) to support research on end-of-life isolation among older adults. The project, titled "Dying Alone: Understanding and Addressing End-of-Life Isolation Among Older Adults," addresses the clinical and public health...
- The National Institute on Aging awarded The Regents of the University of California, San Francisco $736,432 on September 1, 2026, under the Aging Research program (CFDA 93.866) to investigate how healthcare financialization shapes goal-concordant serious illness care in older adults. The recipient will conduct an ethnographic interview study across six hospital sites—two academic medical centers and four affiliated hospitals in two geographic regions—to document mechanisms by which...
- The National Institute on Aging awarded $680,086 to The Regents of the University of California, San Francisco (UCSF) on April 1, 2026, under the Aging Research program (CFDA 93.866) to investigate how changes in primary care clinician work effort affect health outcomes for older adults. The research quantifies the number of Medicare patients affected by primary care clinician turnover and sustained reductions in billed clinical effort, identifies factors associated with these work effort...
- The National Institute on Aging, part of the Department of Health and Human Services, awarded the University of California, Los Angeles $146,750 under the Aging Research program (CFDA 93.866) on July 1, 2026, to identify molecular-neuropathological signatures in Alzheimer's disease, frontotemporal lobar degeneration, and long COVID. The recipient will employ single-cell spatial multi-omics on postmortem brain tissues to characterize molecular and cellular alterations linked to selective...
- The National Institute on Aging awarded the President and Fellows of Harvard College $683,924 on February 1, 2026, under the Aging Research program (CFDA 93.866) to conduct research on patient outcomes and healthcare utilization in U.S. hospices following private equity acquisition. The research examines how private equity acquisition affects hospice patient selection, length of stay, service utilization, live discharge rates, and Medicare spending. The study uses a quasi-experimental approach...
- The National Institute on Aging awarded Kaiser Foundation Hospitals $2.495 million on September 15, 2025, under the Aging Research program (CFDA 93.866) to investigate missed home health care in older adults with Alzheimer's disease and related dementias. The project, titled "Missed Home Health Care in Older Adults with Dementia: Identifying Drivers, Outcomes, and Costs," uses mixed methods to identify correlates and drivers of missed home health care following hospital discharge,...
- The National Institute on Aging (NIA), through its Aging Research Federal Grant Program (CFDA 93.866), awarded a $2,374,537 Project Grant to the Regents of the University of California, San Francisco (UCSF) on Sep 15, 2024. The grant supports a research project titled "Personal Values in Dementia Experience, Caregiving, and Research" that aims to examine how changes in personal values and self-narratives among people with different dementia syndromes impact caregivers and caregiving...
- The National Institute on Aging awarded The University of Chicago $597,239 on September 1, 2026, under the Aging Research program (CFDA 93.866) to support investigation of inpatient rehabilitation facility (IRF) utilization and outcomes for older adult patients with and without Alzheimer's disease or other dementias (ADRD). The research examines comparative value and appropriateness of care delivery across post-acute care settings, specifically comparing higher-cost IRF care—which provides acute...
- The National Institute on Aging awarded The Johns Hopkins University $769,960 under the Aging Research program (CFDA 93.866) on September 1, 2026, for research examining how changes in home health care agency ownership and private capital investment affect access to care, quality of care, and patient outcomes for people living with dementia. The project, which runs through May 31, 2031, investigates the impact of multi-state chain acquisitions and private capital investments on home health...
The National Institute on Aging, a component of the Department of Health and Human Services, awarded $834,775 to the Regents of the University of California, San Francisco on August 15, 2026, under the Aging Research program (CFDA 93.866) to conduct research identifying drivers of hospice disparities for older adults with and without Alzheimer's disease and related dementias (ADRD). The research examines regional hospice market variation as a structural factor driving disparities in hospice access, quality, and outcomes. The study will create novel county-level measures of hospice markets and link them to national Medicare data to evaluate how regional market variation is associated with disparities in hospice outcomes among older adults with and without ADRD. The research leverages California's 2022 hospice moratorium as a natural experiment to examine whether the state public health intervention was associated with changes in hospice market characteristics. The performance period runs through April 30, 2031, with work performed in San Francisco, California. This is a project grant under the Aging Research program, which supports biomedical, social, and behavioral research directed toward understanding the aging process and diseases affecting older adults, with particular emphasis on Alzheimer's disease and related dementias.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $133.6k | 8/14/26 | ||
| Not listed | $701.2k | 8/11/26 |